GLP-1 medications, like Ozempic and Wegovy, mimic natural hormones in the body that regulate blood sugar and insulin levels. They’re used to treat type 2 diabetes and obesity. These drugs curb the ...

This is excellent news! Dr. Saladino (@paulsaladinomd2) explains that prescription weight loss medications like Ozempic work ...

TUESDAY, Nov. 12, 2024 (HealthDay News) -- For patients with ischemic stroke, sodium-glucose cotransporter-2 inhibitors (SGLT ...

Weight loss drugs like Ozempic and Wegovy may provide strong relief from severe osteoarthritis knee pain, new research finds.

GLP-1 receptor agonists and SGLT2 inhibitors, two classes of medications most commonly prescribed to treat Type 2 diabetes or weight loss, may reduce the risk of heart attack, second strokes and death ...

Unplanned pregnancies are still being reported among people using GLP-1 drugs, but now fertility specialists are ...

In the complex landscape of healthcare coverage, only 13 states in the United States have opted to allow Medicaid to cover ...

Novo said supply of Wegovy and Ozempic is in good shape after the drugs were removed from the FDA’s shortage list last week.

SGLT2 inhibitors and GLP-1 receptor agonists exhibit renoprotective effects in patients with CKD with and without diabetes.

You can’t go far lately without seeing news and social media coverage of GLP-1 (glucagon-like peptide-1) receptor agonists ...

Obesity has been a big topic recently, with Novo Nordisk and Eli Lilly leading the way with their GLP-1 agonists Wegovy and ...

In a deal worth up to $285 million initially for the lead program, Novo Nordisk will gain access to Ascendis’ TransCon ...